Maintain Buy, Target Price Lowered to 33.59 CNY; Independent Brand Overseas Expansion Accelerates
AI summary card
Maintain Buy, Target Price Lowered to 33.59 CNY; Independent Brand Overseas Expansion Accelerates
Despite short-term performance pressure from tariffs and raw material costs, the company, as the only pet food enterprise in China with US production capacity, possesses scarce valuation premium; bullish on long-term branding transformation and global capacity release.
- Maintain 'Buy' rating, target price from 54.00 CNY lowered to 33.59 CNY, implied 16.8% upside.
- 2025 and 2026 Q1 revenue growth strong, but net profit dragged by tariffs, raw material costs, and brand investment fell short of expectations.
- Domestic independent brands (WANPY, TOPTREES, ZEAL) revenue up 32.4% YoY, becoming core driver.
- Second US factory expected completion in 2026 Q2-Q3, ramp-up starts H2, helps avoid trade barriers.
- Granted 2026 27x PE valuation, higher than industry average, reflecting US capacity scarcity.
Report interpretation
Overview
Nomura Orient International Securities issued a research report, maintaining 'Buy' rating on China Pet Food (002891.SS), but significantly lowering target price from 54.00 CNY to 33.59 CNY. The report points out that although company 2025 and 2026 Q1 revenue maintained double-digit growth, and domestic independent brands showed bright performance, profit side was under obvious pressure due to Sino-US tariff friction, geopolitical interference, rising raw material costs, and increased brand building investment. Institutions believe, as the only Chinese pet food enterprise with US local production capacity, it possesses scarcity value for coping with trade barriers, medium-to-long term expected to achieve profit repair through product mix upgrade and economies of scale.
Core views
Performance Review & Adjustment: 2025 Company Revenue 52.21 hundred million CNY (YoY +16.9%), Net Profit 3.65 hundred million CNY (YoY -7.3%); 2026 Q1 Revenue 15.33 hundred million CNY (YoY +39.2%), Net Profit 0.73 hundred million CNY (YoY -19.8%). Revenue slightly below expectations mainly due to overseas OEM business slowed to 9.77% growth due to tariffs and geopolitical impact; profit missed expectations originates from overseas gross margin compression, high domestic brand marketing expenses, and exchange rate loss. Accordingly, institutions significantly adjust 2026/2027 Net Profit Forecast down 37.8%/41.6%, and added 2028 earnings forecast. Driver Analysis: Domestic business became growth engine, benefiting from WANPY, TOPTREES and ZEAL three independent brands scaled expansion, domestic revenue up 32.4% YoY. Institutions believe, Chinese pet food industry competition shifting from price war to formula R&D, raw material upgrade, compliance management, and omnichannel execution ability comprehensive contest. Company increasing brand investment though short-term suppresses profit, but helps improve brand asset and medium-to-long-term profit margins. Global Layout & Valuation: Company has capacity in US, New Zealand, Canada etc., among which second US factory expected 2026 Q2-Q3 completion, H2 start capacity ramp-up. This layout makes it only Chinese pet food enterprise with US local production capacity, in Sino-US trade friction background possesses significant scarcity and valuation premium. Therefore, institutions maintain 27x target PE ratio (higher than peer average 24x), based on adjusted 2026 EPS 1.24 CNY, derived new target price 33.59 CNY.
Analysis framework
Institutions adopted 'Fundamental Breakdown + Valuation Reassessment' analysis framework. First, through volume-price breakdown and regional segment analysis, identified high growth of domestic independent brands and obstacles of overseas OEM business, explained divergence of revenue and profit. Second, combined macro trade environment (tariffs, geopolitical) and micro cost structure (raw materials, exchange rates, marketing expenses), adjusted earnings forecast downward. Finally, at valuation level, introduced 'Scarcity Premium' logic, compared peer average valuation, argued why still maintain higher PE multiple in performance downgrade background, thereby derived new target price.
Methodology notes
Relative Valuation Method (P/E) Combined with Scarcity Premium
Institutions use P/E ratio for valuation, and considering company possesses US capacity scarcity, grants higher than industry average valuation multiple, to reflect its risk resistance capability and unique competitive advantages under trade barriers.
Global Capacity Layout Hedges Trade Risks
Analyzes upstream raw material cost volatility and midstream manufacturing link geopolitical risks (e.g. tariffs), points out through downstream market localization production (factory built in US) can effectively transmit and resolve shocks brought by trade barriers.
Brand Asset and Omnichannel Capability Builds Moat
Points out industry competition focus shifted from pure price competition to brand power, R&D ability, and channel execution ability comprehensive competition, company builds brand moat by increasing marketing investment, though short-term sacrifices profit, aims to obtain long-term market share and pricing power.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- China Pet Food (002891.SS)Beneficiary Target: Possesses US local capacity, able to avoid trade barriers; Domestic independent brands high-speed growth.
- Strengths
- Only Chinese pet food enterprise with US capacity; WANPY/ZEAL/TOPTREES brand matrix mature; Global multi-region capacity layout.
- Weaknesses
- Short-term profit eroded by raw material costs, exchange rates and marketing expenses; Overseas OEM business greatly affected by geopolitical events.
- Comparison
- Compared to peers (such as Garba Pets, Petoo), possesses stronger global manufacturing layout and anti-tariff risk capability, valuation enjoys premium.
- Risks
- Domestic competition intensifies; Raw material price fluctuations; US factory capacity ramp-up falls short of expectation.
Key data
- 2025 Revenue52.21 hundred million CNYYoY +16.9%, slightly below expectation
- 2025 Net Profit3.65 hundred million CNYYoY -7.3%, dragged by costs and expenses
- 2026 Q1 Revenue15.33 hundred million CNYYoY +39.2%
- 2026 Q1 Net Profit0.73 hundred million CNYYoY -19.8%
- Domestic Revenue Growth32.4%2025 YoY, driven by independent brands
- 2026F EPS Forecast1.24 CNYSignificantly reduced from previously forecasted 2.00 CNY
- Target PE Ratio27xHigher than peer average 24x, reflects scarcity
- New Target Price33.59 CNYReduced from previous 54.00 CNY, implied 16.8% upside
Impact & implications
Research report believes, short term investors need tolerate profit volatility brought by brand investment and external macro disturbance. Medium-to-long term view, as US new factory produces, company can effectively avoid tariff risks, optimize global supply chain cost structure. Meanwhile, domestic high-end brand line rapid volume increase expected to improve product mix, push gross margin recovery. For market, company valuation logic shifted from simple contract manufacturing to brand operator with global layout capability, its scarcity supports valuation premium.
Risks
- Domestic market competition intensifies
- Raw material price fluctuations
- US factory capacity ramp-up speed slower than expectation
What to watch
- Order acquisition situation and margin improvement degree after second US factory puts into operation
- Scale expansion speed of domestic independent brand new product lines